Anti-FcGR3A-Anti-EGFR Bispecific Antibody

BPS Bioscience

Anti-FcGR3A-Anti-EGFR Bispecific Antibody

7

ELISA

Research Use Only

Monoclonal

≥90%

EGFR

epidermal growth factor receptor

ERBB, ERBB1, ERRP, HER1, NISBD2, NNCIS, PIG61, mENA, epidermal growth factor receptor, EGFR vIII, avian erythroblastic leukemia viral (v-erb-b) oncogene homolog, cell growth inhibiting protein 40, cell proliferation-inducing protein 61, epidermal growth factor receptor tyrosine kinase domain, erb-b2 receptor tyrosine kinase 1, proto-oncogene c-ErbB-1, receptor tyrosine-protein kinase erbB-1

Human

Epidermal growth factor receptor

Anti-FcGR3A-anti-EGFR bispecific IgG antibody, which recognizes FcGR3A (also known as CD16A) and EGFR antigen binding proteins. The amino acid sequences correspond to the sequences from the bispecific EGFR/FcGR3 antigen-binding protein patent WO2019175368A1. This bispecific antibody has been tested for specific binding affinity to purified human FcGR3A and EGFR recombinant protein.

-80°C

41116161

Human